The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug ...

Several major U.S. health insurers announce they will voluntarily speed up and simplify the prior authorization process.

They have already taken the weight-loss sector by storm - now the blockbuster drugs Ozempic and Mounjaro could do the same ...